Lipid metabolism encompasses fatty-acid synthesis, beta-oxidation, lipolysis, and lipoprotein trafficking. GLP-1 and GIP receptor agonists influence lipid metabolism through multiple mechanisms including reduced hepatic lipid production, increased fatty-acid oxidation, and changes in adipokine signaling. Visceral and hepatic fat reduction are common trial endpoints.
Research use only. This definition is an educational reference, not medical advice or dosing guidance.